NanoVibronix, Inc. carries a market capitalization of 1.51M, placing it among publicly traded companies globally. Its enterprise value stands at -1.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.51M |
| Enterprise Value | -1.86M |
NanoVibronix, Inc. currently has 787,359.00 shares outstanding.
| Shares Outstanding | 787,359.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.02, and the price-to-book ratio stands at 0.00.
| PE Ratio | N/A |
| PS Ratio | 0.02 |
| PB Ratio | 0.00 |
| P/TBV Ratio | -0.01 |
| P/FCF Ratio | -0.01 |
| P/OCF Ratio | -0.01 |
| EV / Sales | 1.49 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
NanoVibronix, Inc. maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.25, indicating elevated leverage, while an interest coverage ratio of -29.49 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.05 |
| Quick Ratio | 0.71 |
| Debt / Equity | 5.25 |
| Debt / EBITDA | -0.27 |
| Interest Coverage | -29.49 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -31.11 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.69 |
| Income Tax | 85,000.00 |
| Effective Tax Rate | N/A |
NanoVibronix, Inc.'s stock has declined approximately -97.05426% over the past 52 weeks. The 50-day moving average sits at 4.70, while the 200-day moving average is 15.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.05426% |
| 50-Day Moving Average | 4.70 |
| 200-Day Moving Average | 15.96 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, NanoVibronix, Inc. generated 2.34M in revenue and converted that into -8.89M in net income, yielding earnings per share of -195.42. EBITDA reached -7.79M, while operating income came in at -8.17M.
| Revenue | 2.34M |
| Gross Profit | 750,000.00 |
| Operating Income | -8.17M |
| Pretax Income | -8.81M |
| Net Income | -8.89M |
| EBITDA | -7.79M |
| EBIT | -8.17M |
| Earnings Per Share (EPS) | -195.42 |
NanoVibronix, Inc. holds 4.03M in cash and equivalents against 2.13M in total debt, resulting in a net debt position of -2.05M. Total book value stands at -75.98M, with working capital of 349,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 4.03M |
| Total Debt | 2.13M |
| Net Debt | -2.05M |
| Equity (Book Value) | -75.98M |
| Book Value Per Share | -1,669.23 |
| Working Capital | 349,000.00 |
NanoVibronix, Inc. produced -6.11M in operating cash flow over the past twelve months. After subtracting -9,000.00 in capital expenditures, free cash flow totaled -6.12M - equivalent to -134.43 per share.
| Operating Cash Flow | -6.11M |
| Capital Expenditures | -9,000.00 |
| Free Cash Flow | -6.12M |
| FCF Per Share | -134.43 |
NanoVibronix, Inc. operates with a gross margin of 32.06, reflecting its pricing power and cost economics. The operating margin of -349.21 and net profit margin of -380.29 provide insight into operational efficiency.
| Gross Margin | 32.06 |
| Operating Margin | -349.21 |
| Pretax Margin | -376.66 |
| Profit Margin | -380.29 |
| EBITDA Margin | -332.88 |
The company's payout ratio of 3.72 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 3.72 |
| Shareholder Yield | -18,654.50 |
| FCF Yield | -14,455.88 |
NanoVibronix, Inc.'s most recent stock split took place on August 12, 2025 with a 10:1 split ratio.
| Last Split Date | 8/12/2025 |
| Split Ratio | 10:1 |
NanoVibronix, Inc. posts an Altman Z-Score of -17.80, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -17.80 |